Meet our 2021 Employee Champions. We recognize individuals who strive to advance science and support innovation so that patients around the world can get the medicines and treatments they need. This year’s recipients have demonstrated commitment and resiliency that goes above and beyond expectations.

Dr. Raja Mangipudy

Head of WRDM Drug Safety Research and Development and Comparative Medicine | Pfizer

As the site leader of one of Pfizer’s largest worldwide research & development sites in Groton, CT, Raja understands the power of colleagues’ voices and engagement. He has become a welcome advocate and partner to Pfizer’s US Government Relations team — providing forums for colleagues to learn more about public policy issues and new opportunities

Kathryn Mathias

Associate Director, Launch Excellence | Takeda Pharmaceuticals America, Inc.

kathryn-mathias

Kathryn plays a key role in Takeda’s grassroots action network — including the launch of a new employee Ambassador program that educates and connects employees from all disciplines with public affairs projects. To date, the Ambassadors program has educated three cohorts of cross-functional colleagues.

Stephen Mayclin

Crystallography Lead | UCB

Stephen has been with UCB since 2015, working on protein crystallization and X-ray diffraction, producing high-quality structures supporting the development of new chemical and biologic therapies. During his tenure, Stephen has also developed a passion for advocacy — leading lab site visits and participating in Researcher Fly-ins in both Olympia and DC. Stephen also played

Michael McDermott

President, Pfizer Global Supply | Pfizer

Michael leads Pfizer Global Supply (PGS), an organization of more than 26,000 global colleagues, who are responsible for manufacturing and global distribution of the Pfizer-BioNTech COIVD-19 vaccine. His leadership has been pivotal to the company’s efforts to enhance the COVID-19 vaccine production and distribution process. He has also taken the time to share Pfizer’s vaccine

Dr. Abena Osei-Wusu

Medical Director of Atherosclerosis | Novartis

Dr. Osei-Wusu provides critical input into the strategy, development and implementation of studies in the company’s cardiovascular program. She has represented Novartis at both the American College of Cardiology and the American Heart Association Scientific Congresses. And is also an active member of Women of Color in Pharma. Over the last year, she has partnered

Don Raineri, Pharm.D.

Vice President, Regulatory Affairs-U.S. and Global Head of Labeling & Regulatory Intelligence | Astellas

In the past year, Don has helped lead the company’s efforts to enhance diversity in clinical trials participation, including shepherding development of an implementation plan specific to PhRMA’s revised clinical trials principles. Don has also represented Astellas in discussions on the reauthorization of the Prescription Drug User Fee Act (PDUFA), working to encourage an efficient

Deborah Reardon

Director of Access Solutions | Boehringer Ingelheim

Deb consistently goes beyond her traditional day-to-day responsibilities to advance policy priorities at both the state and federal level. Her ability to simply translate complicated schematics has been invaluable in educating and engaging diverse stakeholders on some of the industry’s most pressing policy fronts — including co-pay accumulator bans, rebate pass-through and improved transparency around

David Riggs

Sr. Director | Eli Lilly and Company

David and his colleague, Caroline Rosewell, were the team leaders in the company’s efforts to set up monoclonal antibody infusion clinics across the state of Indiana. These clinics not only helped get the treatment out to at-risk patients across the state, but they also served as an important tutorial and “how to” for hospitals and

Caroline Rosewell

Sr. Director | Eli Lilly and Company

Caroline and her colleague, David Riggs, were the team leaders in the company’s efforts to set up monoclonal antibody infusion clinics across the state of Indiana. These clinics not only helped get the treatment out to at-risk patients across the state, but they also served as an important tutorial and “how to” for hospitals and

Sanofi Protein Sciences Team

Sanofi

The Sanofi Protein Sciences team is being recognized for their extensive engagement with federal and state legislators. When Connecticut Gov. Lamont was newly elected, the team hosted him and Lt. Gov. Bysiewicz at their Connecticut site to learn about the research and development on the COVID-19 vaccine and their flu vaccine innovative technology. Since that